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Human Chitotriosidase: Catalytic 
Domain or Carbohydrate Binding 
Module, Who’s Leading HCHT’s 
Biological Function
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Legrand1, Raffaella Parente1, Denis Baurain  3, Moreno Galleni1, Morten Sørlie4 & Marylène 
Vandevenne1
Chitin is an important structural component of numerous fungal pathogens and parasitic nematodes. 
The human macrophage chitotriosidase (HCHT) is a chitinase that hydrolyses glycosidic bonds between 
the N-acetyl-D-glucosamine units of this biopolymer. HCHT belongs to the Glycoside Hydrolase (GH) 
superfamily and contains a well-characterized catalytic domain appended to a chitin-binding domain 
(ChBDCHIT1). Although its precise biological function remains unclear, HCHT has been described to be 
involved in innate immunity. In this study, the molecular basis for interaction with insoluble chitin as 
well as with soluble chito-oligosaccharides has been determined. The results suggest a new mechanism 
as a common binding mode for many Carbohydrate Binding Modules (CBMs). Furthermore, using a 
phylogenetic approach, we have analysed the modularity of HCHT and investigated the evolutionary 
paths of its catalytic and chitin binding domains. The phylogenetic analyses indicate that the 
ChBDCHIT1 domain dictates the biological function of HCHT and not its appended catalytic domain. This 
observation may also be a general feature of GHs. Altogether, our data have led us to postulate and 
discuss that HCHT acts as an immune catalyser.
Carbohydrate recognition processes are involved in numerous regulatory pathways such as cell signalling and 
proliferation, fertilization, embryogenesis and in diseases like cancers. Carbohydrates also play a critical role in 
pathogen recognition, inflammation and innate immune responses through a large array of carbohydrate bind-
ing proteins1. Chitin, a water-insoluble homopolysaccharide composed of β-1,4-linked N-acetyl-D-glucosamine 
(GlcNAc) units, is an abundant structural component of arthropods and various infectious organisms like proto-
zoans (e.g. Plasmodium falciparum), nematodes and fungi2, 3. As mammals do not produce chitin, this polymer is 
likely a strategic target for innate immune agents. Defense proteins, including lectins, are known to play a crucial 
role in the initiation of innate immune mechanisms4. These carbohydrate binding proteins include numerous 
members, which are notably synthetized by many organisms including plants and animals, thereby highlighting 
their ubiquity and necessity for survival5. Some of these lectins are able to bind reversibly to chitin and include a 
conserved structural motif termed “hevein-fold”; which is rich in polar and aromatic residues6. Genes encoding 
these motifs, associated or not with a catalytic domain, are usually expressed after exposure to chitin-containing 
pathogens. Among other characteristics, lectins have been shown to bear remarkable anti-fungal properties7, 8. 
The macrophage chitotriosidase (HCHT) is one of the three active chitinases synthetized by humans, together 
with acidic mammalian chitinase (AMCase) and the recently discovered exochitinase, chitobiase (CTBS)9–11. 
This protein is synthetized as a 50-kDa soluble monomeric enzyme that is able to hydrolyse colloidal chitin. This 
modular protein is composed of a catalytic domain that belongs to family 18 of glycoside hydrolases (GH18) 
and of a carbohydrate-binding module, named ChBDCHIT1. The latter domain is stabilized by 3 disulphide bonds 
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and was classified in the CAZy (Carbohydrate-Active enZYmes) database (http://www.cazy.org) in family 14 
(CBM14). This family includes small binding domains like lectin-like proteins and is characterised by the pres-
ence of the highly conserved “hevein-fold”. Among the three human chitinases, HCHT has drawn most of the 
attention and is nowadays known to be involved in innate immunity for several reasons. Firstly, this enzyme is 
mostly synthesized by human macrophages that play a critical role in innate immunity12. Secondly, HCHT is 
overexpressed in several pro-inflammatory diseases and in various human sub-populations more exposed to 
infectious organisms13, 14. Finally, the expression of HCHT’s gene can be modulated by the action of cytokines and 
different immune inducers15. However, the precise role of HCHT in innate immunity and its associated molecular 
mechanisms remain unclear. Indeed, most of the work reported on this enzyme focused on the association of its 
expression with various diseases. Hence, HCHT is used as a biomarker for the diagnostic of Gaucher disease, 
sarcoidosis, glucose intolerance, β-thalassemia and World Trade Center lung injury16–18.
In bacteria, insoluble chitin hydrolysis requires the synergic activity of several chitinases. For example, Serratia 
marcescens expresses a battery of chitinases with complementary activities including exochitinases (ChiA and 
ChiB), endochitinases (ChiC), a N-acetyl-hexosaminidase (chitobiase) and a lytic polysaccharide monooxygen-
ase (CBP21) that act together to hydrolyse efficiently chitin containing structures in order to generate an energy 
source19, 20. In human, in the context of innate immunity, hydrolysis of chitin-containing pathogens would also 
require complementary chitinase activities. Nevertheless, HCHT appears to be the only chitinase secreted by 
macrophages. It seems unlikely that HCHT alone could efficiently degrade chitin-containing microorganisms. 
This intriguing observation explains why the exact function of this enzyme in the context of innate immunity 
remains unclear.
The aim of this study was to analyse the chitin-binding properties of HCHT chitin binding domain 
(ChBDCHIT1). Our data provide the molecular basis for chitin recognition by ChBDCHIT1 and, given the high 
conservation of the residues involved in chitin binding amongst CBMs 14 as well as other CBM families, we pos-
tulated that this binding mode is a hallmark of CBM-carbohydrate interactions.
Moreover, we have interrogated the biological function of HCHT, and more specifically we attempted to 
understand how such an atypical association between a lectin-like CBM14 (ChBDCHIT1) and a glycoside hydrolase 
(GH18) has been conserved through evolution to generate HCHT homologues involved in defense mechanisms. 
Our data suggest that ChBDCHIT1 has evolved by recruiting a glycoside hydrolase domain, initially used for meta-
bolic purposes in other organisms, to become an important component of innate immunity in humans.
Results
Interaction between ChBDCHIT1-49 and carbohydrates. In order to easily monitor the chitin bind-
ing activity of ChBDCHIT1, we inserted the 49 C-terminal residues of HCHT into the BlaP β-lactamase and the 
chitin binding activity of the resulting hybrid protein was monitored using the β-lactamase enzymatic activity 
as a reporter as previously described21. Our data indicated that ChBDCHIT1-49 displayed chitin-binding activity 
on chitin-coated magnetic beads (Fig. 1A). Since N-acetyl glucosamine (GlcNAc) is the monomeric subunit of 
chitin, we have investigated the interaction of ChBDCHIT1-49 with different soluble chito-oligosaccharide deriv-
atives (GlcNAc1, GlcNAc2, GlcNAc4 and GlcNAc6). In practice, the protein was pre-incubated with a given 
Figure 1. Binding assays of BP-ChBDCHIT1-49 towards different ligands. (A) Insoluble chitin was first used as a 
ligand to compare the binding efficiency of the protein used in the present study (BP-ChBDCHIT1-49) and the one 
reported in our previous work21 (BP-ChBDCHIT1-72) using the reporter enzymatic activity of the carrier protein 
BlaP. The β-lactamase BlaP without any inserted ChBDCHIT1 (labelled BP) was used as a negative control (B) 
Hyaluronan (HA; 50% acetylated; black) and peptidoglycan (PG; 50% acetylated; hatched) were also tested 
using the same procedure. (C) GlcNAc1, GlcNAc2, GlcNAc4 and GlcNAc6 (respectively G1, G2, G4 and G6) were 
used as competitors. An equimolar amount of competitor was pre-incubated with the protein before incubating 
the mixture with insoluble chitin. Except for GlcNAc1 (*), all competitors showed a similar inhibition effect 
(**).
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chito-oligosaccharide (acting as a competitor) and then the mixture was incubated with insoluble chitin before 
measuring the β-lactamase activity immobilized on insoluble chitin. The data showed a low competition effect of 
GlcNAc1, whereas all the other chito-oligomers showed a significant chitin binding inhibition (Fig. 1C). Notably, 
the inhibition effect of GlcNAc2, GlcNAc4 and GlcNAc6 were in the same order of magnitude. These data suggest 
that the interaction surface of ChBDCHIT1-49 is relatively small and that the residues involved in binding are local-
ised to a limited area.
Other polysaccharides were also tested and ChBDCHIT1-49 was found to bind hyaluronan (50% acetylated). 
Interestingly, no interaction was detected for Escherichia coli peptidoglycan (Fig. 1B), which also includes 
GlcNAc units.
Molecular basis for chitin recognition. The analysis of the recently solved structure of ChBDCHIT1-49 
(PDB ID: 5HBF; Fig. 2A) has revealed the presence of a specific structural motif that is also found in tachy-
citin (PDB ID: 1DQC; Fig. 2C) and hevein (PDB ID: 1T0W)1, 22, 23. This motif known as the “hevein-fold” is 
well-conserved within CBM14 family and has been shown to be involved in chitin binding1. In ChBDCHIT1-49, this 
“hevein” motif is stabilized by two disulphide bonds (Cys450-Cys463, Cys460-Cys462).
Alanine scanning was used to investigate the “hevein” motif. Each of the 12 residues contained within the 
“hevein” motif of ChBDCHIT1-49 was substituted by alanine using directed mutagenesis. In order to preserve the 
structural integrity of the protein, cysteines and Phe456 were not mutated. All the mutants were expressed and 
purified as hybrid β-lactamases in order to use the enzymatic activity of the β-lactamase moiety to monitor the 
chitin-binding activity of ChBDCHIT1-49 mutants. The integrity of the fold as well as the functionality of the cor-
responding mutated domains were probed using Far-UV CD spectra and enzymatic activity assays, respectively 
(Figure S1, Table S1). The CD measurements were performed on the isolated ChBDCHIT1-49 mutants whereas 
the β-lactamase enzymatic activity assays were recorded on the corresponding hybrid proteins. In general, the 
chitin binding affinities of the mutants displayed reduced binding affinity. Mutants were classified into three 
different groups according to the impact of the mutation on the binding affinity: (i) low impact, Thr452, Gly453, 
Val455, Ser459 and Asn466; (ii) medium impact, Ser457, Asn458, Lys461 and Thr464; (iii) and high impact, 
Pro451, Leu454 and Trp465 (Fig. 3A,B,C). The deletion of Trp465 has previously been described to have a dele-
terious effect on binding24, which is in good agreement with our data, since substitution of this residue showed 
the strongest impact on ChBDCHIT1-49 binding activity (Fig. 3A). The π-electrons on the aromatic residue most 
likely interact with the C-H bond in the pyranose ring of the GlcNAc unit. Besides Trp465, other apolar resi-
dues (Pro451, Gly453, Leu454 and Val455), mostly located in the same loop, appear to be important for binding 
(Fig. 3A). On the ChBDCHIT1-49 structure, these residues form a hydrophobic pocket that stabilizes the loop con-
formation and consequently the orientation of Trp465 side chain (Fig. 3E). Furthermore, substitution of several 
polar residues (Ser457, Asn458, Ser459, Thr464 and Asn466) has an impact on chitin binding. These residues 
likely contribute to binding by providing hydrogen bonds with the ligand (Fig. 3A,D,F). Indeed, polar residues 
are commonly found in the protein-sugar interfaces25, 26.
Interaction of ChBDCHIT1-49 with chito-oligosaccharides. 15N-HSQC spectra of ChBDCHIT1-49 were 
recorded before and after addition of GlcNAc3. The percentages of backbone and side chain assignment covered 
92% and 82% of the protein domain, respectively. The side-chain chemical shifts of Asn466 (Hδ1/Nδ1 and Hδ2/
Nδ2) and Trp465 (Hε1/Nε1) were the most perturbed in the 15N-HSQC spectra upon titration of the ligands. 
These side-chains, corresponding to the substrate interaction surface, are shown in Fig. 4B. As no other peaks 
were significantly affected, chemical shift data for these peaks were used to calculate a Kd for GlcNAc3 of 9.9 ± 0.8 
(SD) mM (Figs 4A and S3B). The measured changes in chemical shifts induced by GlcNAc2 were overall too low 
to calculate a Kd (Figure S3C), however this observation in itself shows that ChBDCHIT1-49 binds GlcNAc3 stronger 
than GlcNAc2.
Figure 2. Structures of ChBDCHIT1-49, AMCase (3D model) and tachycitin (“hevein-fold” motifs are shown in 
transparent surface representation). (A) Crystal structure of ChBDCHIT1-49 (PDB ID: 5HBF). The aromatic and 
polar residues are represented in blue sticks (conserved disulphide bonds are represented as green lines). (B) 3D 
model of AMCase CBM14 (YASARA) built by sequence homology using the ChBDCHIT1-49 X-ray 3D structure 
as template. The corresponding residues shown in Fig. 2A are highlighted in blue sticks. (C) NMR structure of 
tachycitin (PDB ID: 1DQC) where corresponding residues shown in Fig. 2A are highlighted in blue sticks.
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Phylogenetic Study. ChBDCHIT1-49 is part of the CBM14 family. In HCHT, this CBM is associated 
by a linker region to a catalytic domain belonging to the GH18 family. Although phylogenetic studies have pre-
viously been reported on the GH18 family27 and CBMs1428, we have analyzed the taxonomic distribution of 
CBMs 14, GHs 18 and HCHT in order to trace back the possible origin and evolution of these domains/pro-
teins (Fig. 5A). Hence, we have noticed that GHs 18 proteins are present in genomes of all three domains of 
Life (Archaea, Bacteria, Eukaryota) and of some viruses. In contrast, CBM14 domains are restricted to specific 
groups of Eukaryota, suggesting that the appearance of this domain family is more recent. While both domain 
families (GH18 and CBM14) have coexisted since early eukaryotes [as deduced from their occurrence in both 
unikont and bikont lineages]29, HCHT-like proteins apparently only assembled in the ancestor of bilaterian ani-
mals (i.e., after the divergence of sponges, ctenophores and cnidarians; Fig. 5A). Next we analysed the origin of 
“hevein-fold” containing proteins, including tachycitin and hevein itself. Tachycitin is also a CBM14 that shares 
34% amino acid sequence identity and structure conservation with ChBDCHIT1-49. In contrast, hevein, the first 
protein in which the “hevein-fold” has been described and characterized, is related to the CBM18 family and is 
strictly present in Viridiplantae, Fungi and viruses genomes (Fig. 5A).
Therefore, our data support the fact that the structure similarity between the “hevein-folds” of CBMs 14 and 
CBMs 18 appears to be the result of convergent evolution, which is commonly admitted by the scientific com-
munity23. Finally, we built domain trees for CBM14 and GH18 families. The CBM14 tree features a subtree that 
includes all CBMs 14 involved in HCHT-like architectures (Fig. 5B), whereas, in the GH18 tree, most (but not 
all) of the GHs 18 involved in HCHT-like architectures are located in the same subtree (Fig. 5C). Considering the 
weak resolution of these two domain trees, it is very possible that the additional HCHT-like GH18 domains that 
are not part of the main HCHT-like subtree are simply misplaced by phylogenetic inference. This would mean 
that HCHT-like proteins are all homologous because they have a single origin, tracing back to the original associ-
ation of a CBM14 domain and of a GH18 domain in a common ancestor of Bilaterians.
Discussion
Our work focuses on the CBM of the HCHT and has highlighted several features of this domain that might be 
applied to many other CBMs. First, we have identified the chitin binding residues of ChBDCHIT1-49. We have also 
Figure 3. Molecular mechanism of chitin binding and structural features of ChBDCHIT1-49. (A) The diagram 
shows the chitin binding efficiencies of single mutants generated by directed mutagenesis of predicted binding 
residues. All the protein mutants (except T452A) displayed reduced binding activities and were classified in 
three different groups depending on the impact of the mutation: (i) low impact *, (ii) medium impact ** and 
(iii) high impact ***. (B) X-ray 3D structure of ChBDCHIT1-49 solved by Fadel and coworkers (PDB ID: 5HBF) 
where the “hevein-fold” motif is shown in surface representation whereas the rest of the structure is represented 
in cartoon (disulphide bonds are colored in green). Mutated residues were colored in yellow, orange and red 
depending respectively on the low, medium and high impact of the mutation on the chitin binding function. 
(C) 90° rotated view of the structure. (D) Detailed view of polar residues (in blue sticks) and Trp465 (in red) in 
the “hevein-fold” motif of ChBDCHIT1-49 (disulphide bonds in green). (E) Representation of key residues (P451, 
G453, L454 and V455) involved in the hydrophobic pocket which stabilises Trp465 orientation (disulphide 
bonds in green). (F) Surface representation of the binding surface of ChBDCHIT1-49 highlighting the key aromatic 
residue Trp465 and the key polar residues S457, N458, S459, T464 and N458 (blue sticks) directly involved in 
chitin binding (disulphide bonds in green).
www.nature.com/scientificreports/
5Scientific RepoRts | 7: 2768  | DOI:10.1038/s41598-017-02382-z
characterized and quantified the interaction between ChBDCHIT1-49 and small chito-oligosaccharides using NMR 
spectroscopy and competition binding assays. Our data indicate that although ChBDCHIT1-49 interacts tightly to 
insoluble chitin, the measured affinities for chito-oligosaccharides are weak with dissociation constant values 
in the mM range. A phylogenetic study was also conducted to analyze the evolutionary paths of both domains 
included in HCHT (CBM14 and GH18) in order to determine when these domains were combined to give the 
GH18-CBM14 architecture found in HCHT and how this association is related to the biological role of this chiti-
nase in innate immunity.
Figure 4. ChBDCHIT1-49 interaction with GlcNAc3 and binding surface. (A) Overlay of an area of interest from 
the 15N-HSQC spectrum for 0.20 mM ChBDCHIT1-49 in 50 mM phosphate buffer pH 7.0 recorded at 25 °C (black) 
in the presence of 4.5 mM (red) and 25 mM GlcNAc3 (blue). The arrows indicate direction of the change in 
chemical shift upon titration. (B) The binding surface mapped on the structure of ChBDCHIT1-49, where the side 
chain W465 and N466 are showed in red.
Figure 5. Phylogenetic analyses. (A) Reference phylogenetic tree on which are mapped the results of genome 
mining for chitotriosidase (HCHT-like), tachycitin and hevein proteins, as well as GH18 and CBM14 domains. 
The number of representative species are written in brackets. (B) Schematic tree of CBM14 domains, in which 
families integrated in HCHT-like architectures are colored in red (families tagged tachycitin are colored in 
blue). (C) Schematic tree of GH18 domains, in which families integrated in HCHT-like architectures are colored 
in red (families tagged tachycitin shown in blue).
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A hydrophobic pocket present on CHBDCHIT1-49 “hevein” motif important for chitin bind-
ing. Our alanine scanning experiment has highlighted the presence of a hydrophobic pocket that includes 
Leu454 and Val455, both located in a loop induced by Pro451. We hypothesized that this hydrophobic pocket 
orients the Trp465 indole ring (Fig. 3E) for chitin binding. Molecular dynamic simulations (YASARA) performed 
on the Leu454Ala mutant; which presented the most impaired chitin binding activity, support this hypothesis. 
Indeed, the Trp465 indole side chain of the generated mutant exhibits higher flexibility and display more con-
formational freedom (Figure S2). These observations suggest that Leu454 plays an important role in orientating 
Trp465 side chain. Also, Pro451, Gly453, Leu454 and Trp465 are relatively well conserved through CBMs 14, 
which suggests that this binding mechanism can be generalizable to other CBMs 14 (Fig. 2). Our alanine scan-
ning experiment has also highlighted that mutation of five polar residues (Ser457, Asn458, Ser459, Thr464 and 
Asn466) decreased the chitin binding efficiency. These residues are all located below the Trp465 side chain and 
well positioned to form hydrogen bonds (Fig. 3D,F). We postulated a chitin binding mechanism for ChBDCHIT1-49 
where Trp465 oriented by its hydrophobic pocket recognizes and interacts with a first GlcNAc unit of the polysac-
charide. Besides this main interaction, polar residues located below Trp465 seem perfectly positioned to interact 
with a second and probably a third GlcNAc unit. This molecular mechanism reflects very well the binding mech-
anism of Type C CBMs, where essentially polar residues located in loops and few aromatic residues are directly 
involved in chitin recognition6.
The chitin-binding surface of ChBDCHIT1-49 can efficiently fit a minimum of two GlcNAc 
units. Our competition binding assays presented in Fig. 1C has highlighted important information regarding 
the chitin binding surface of ChBDCHIT1-49. These data showed that the smallest chito-oligosaccharide able to 
compete with insoluble chitin is GlcNAc2. Importantly, GlcNAc1 showed a much lower inhibition effect com-
pared to GlcNAc2. This suggests that at least two GlcNAc units are required to form a stable complex. Moreover, 
NMR titration showed that a third GlcNAc unit could extend the surface area of the interaction (Figs 4A and S3). 
Notably, these data contrast with our previous study that didn’t show any chitin-binding inhibition of ChBDCHIT1 
by the chito-oligomers30. In the present study, we used another type of chitin (chitin-coated magnetic beads) 
rather than α-crystalline chitin in our previous work. In addition, the amount of chitin that we used herein was 
much lower compared to our previous study, which placed us in better condition to see a chitin binding inhibition 
by chito-oligosccharides given their low binding affinity (Kds in the mM range) for ChBDCHIT1.
It is also interesting to comment on the difference in the binding affinities of ChBDCHIT1-49 towards soluble 
chito-oligosaccharides and crystalline chitin. Indeed, although it is difficult to quantify crystalline chitin inter-
action given the insoluble character of this ligand, we estimated that this interaction is tight given the harsh and 
denaturing conditions required to remove ChBDCHIT1-49 from a crystalline chitin support. In contrast, the meas-
ured Kds for chito-oligosaccharides are in the high mM range, which is weak (Figs 4A and S3B). In the context of 
chitin hydrolysis by HCHT, the weak affinity for small chito-oligosaccharides, which are the hydrolysis products 
of the enzymatic reaction, is an advantageous feature that avoids ChBDCHIT1-49’s binding inhibition, which main-
tains HCHT efficient towards crystalline chitin.
New insights into the modularity of HCHT using a phylogenetic study approach. HCHT is a 
modular enzyme composed of a GH18 (catalytic domain) and a CBM14 and is known to be involved in innate 
immunity by indirect evidences (see Introduction). In this work, we have performed a phylogenetic study (Fig. 5) 
on the catalytic and chitin binding domains of HCHT. The results showed that GH18-containing genes are found 
in genomes of all domains of life and that this ancestral family of catalytic domains is present in numerous mod-
ular enzymes involved in various biological processes20, 31–33. It is therefore not surprising that they are associ-
ated to a wide variety of domains as it is illustrated by the 377 different architectures classified in Pfam database 
(http://pfam.xfam.org). In contrast, CBMs 14 are only found in Eukaryota (Fig. 5A), which implies that this pro-
tein family is related to strictly eukaryotic biological functions like innate immunity. Interestingly, according to 
Pfam database CBMs 14 are mostly associated with domains involved in defense/immune functions.
Conservation of the HCHT-like architecture only occurred from Bilateria (Fig. 5A). This lineage includes ani-
mals with higher complexity and presumably, more developed immune systems. In these bilaterians, HCHT-like 
proteins were described as a component of defense and development34. All these observations led us to an unex-
pected conclusion: the leader domain that dictates the biological function and dominates the biological activity of 
HCHT might not be the catalytic domain but rather the CBM14. If this hypothesis is confirmed, it will be of cru-
cial importance because it would allow us to better understand and predict the biological role of CBM-containing 
proteins.
Conclusion
Altogether, the data presented in this work bring new insights into the biological function of HCHT. Although 
there are several evidences that link HCHT to immunity, the precise role of this chitinase in human remains 
unclear. It is reasonable to postulate that the presence of ChBDCHIT1-49 facilitates the recognition of small and 
hardly accessible motifs in different chitin types. These features probably enhance HCHT’s capability to be effi-
cient towards a huge diversity of chitin containing pathogens. Since chito-oligosaccharides were recently shown 
to display a higher immunogenicity compared to insoluble chitin35, the lectin-like behaviour of ChBDCHIT1-49 
might confer to HCHT the ability to enhance the inflammatory response against a wide variety of chitin contain-
ing pathogens by releasing immunogenic chito-oligosaccharides and therefore acting as an immune catalyser that 
can lead to a recruitment of additional immune actors.
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Methods
Construction of the Genes Encoding the Hybrid β-lactamases. The genes encoding the chitin-bind-
ing domains ChBDCHIT1-72 (residues Pro395 to Asn466) and ChBDCHIT1-49 (residues Thr418 to Asn466) of the 
HCHT (Uniprot number: Q13231) were amplified by PCR and inserted into the gene coding for the class A 
β-lactamase exo-small BlaP (BP)36 previously cloned in the expression vector pET26b(+). The insertion site is 
located between residues Asp197 and Lys198 of the β-lactamase and the insertions of the gene fragments into 
the BlaP gene were performed as described in our previous studies21, 30, 37, 38. It is important to note that, in our 
previous work, we used a slightly longer ChBDCHIT1 that included the 72 C-terminal residues of HCHT (residues 
Pro395 to Asn466), however based on sequence alignments; we noticed that only the 49 C-terminal residues of 
ChBDCHIT1 were conserved. In addition previous studies published by Tjoelker and coworkers24 as well as Fadel 
and coworkers22 confirmed that the minimum length chitin-binding domain is ChBDCHIT1-49. This is why we 
shortened the domain down to 49 residues. Furthermore, the inserted ChBDCHIT1-49 gene was surrounded by 
two thrombin cleavage sites to release the isolated ChBDCHIT1 domain after production and purification when 
needed as reported previously21. The resulting genetic construct, called pET26b(+)-BP-ChBDCHIT1-49, was used 
to express the hybrid β-lactamases harbouring both the pel B signal peptide for periplasmic secretion and a His6 
tag sequence at the N-terminal and C-terminal extremities, respectively.
Alanine Scanning Mutagenesis. We selected a subset of 12 residues present on the predicted 
chitin-binding surface of ChBDCHIT1-49 for substitution into alanine. The 12 single mutants of the protein 
BP-ChBDCHIT1-49 were generated using the Quick-Change Multi Site-Directed Mutagenesis kit (Agilent 
Technologies) following the manufacturer’s instructions. Briefly, mixtures of 50% Phusion PCR Master Mix 
(Thermo Fisher Scientific), 5% DMSO, 100 ng of template DNA and 2 mM of primers were submitted to the fol-
lowing PCR program: 30 s at 98 °C, 10 s at 98 °C, 30 s at 42 °C and 15 s at 72 °C (30 cycles), followed by a final step 
at 72 °C for 10 min. The PCR products were then digested by DpnI in FastDigest Buffer (Thermo Fisher Scientific) 
for 10 min at 37 °C to remove template DNA. Finally 10 μL of the resulting mutated plasmids were used to trans-
form E. coli DH5α competent cells for plasmid amplification.
Hybrid Protein Expression and Purification. All hybrid proteins were expressed in E. coli BL21(DE3). 
Transformed cells were cultured at 37 °C in Terrific Broth medium supplemented with 50 μg/mL kanamycin until 
OD600nm reached 2.5. Cultures temperature were then decreased to 18 °C for 30 min before proceeding to the 
induction of protein expression by the addition of isopropyl β-thiogalactopyranoside (IPTG) to a final concen-
tration of 1 mM. Cultures were grown for 14 h at 18 °C. Cells were harvested by centrifugation (twice) and resus-
pended successively in two distinct periplasmic extraction buffers: firstly in 1/10th volume of 20 mM Tris 600 mM 
sucrose 5 mM EDTA pH 8.0 at 37 °C and secondly in 1/4th volume of 5 mM MgSO4 at 4 °C. Each periplasmic 
extract was supplemented with one tablet of complete Protease Inhibitor Cocktail (Roche).
Periplasmic proteins were loaded on a 5 mL Bio-ScaleTM Mini ProfinityTM IMAC column (BIO-RAD) equil-
ibrated in 300 mM KCl, 50 mM KH2PO4 and 5 mM imidazol pH 8.0. The column was successively washed with 
300 mM KCl, 50 mM KH2PO4, 10 mM imidazol pH 8.0 and the elution was performed with 300 mM KCl, 50 mM 
KH2PO4 and 250 mM imidazol pH 8.0. Imidazol was immediately removed using a 50 ml Bio-ScaleTM Mini 
Bio-gel® P-6 Desalting column (BIO-RAD). Protein purity level and homogeneity were confirmed by SDS-PAGE 
and UV-Visible (125–400 nm) spectra. Protein concentrations were determined by UV absorbance at 280 nm.
Isolated native and mutated ChBDCHIT1-49 were released from their carrier protein BlaP by thrombin cleavage 
as previously described21. In this study, isolated ChBDCHIT1-49 domains were purified by molecular exclusion chro-
matography using XK 26/100 SuperDex 75 PrepGrade column (GE Healthcare) equilibrated in 150 mM NaCl 
50 mM phosphate buffer pH 7.5 (PBS).
Isotopic Labelled Protein Expression and Production for NMR studies. 13C, 15N or 15N ChBDCHIT1-49 
samples were expressed in E. coli BL21(DE3) cells. Pre-culture were grown in LB medium (10 g/L tryptone, 5 g/L 
yeast extract and 5 g/L NaCl) supplemented with 50 μg/mL kanamycin in a shaking incubator at 225 rpm, 30 °C 
overnight. A 2L LB main culture with 50 μg/mL kanamycin was inoculated with 1% of the overnight culture and 
grown in a shaking incubator at 225 rpm, 30 °C to OD600nm reaches ∼0.8. Cultures were centrifuged at 4,500 g 
for 10 min and resuspended on ice in 500 mL M9 media (6 g/L Na2HPO4, 3 g/L KH2PO4, 0.5 g/L NaCl) supple-
mented with 99% (15NH4)2SO4, 98% 13C6-D-glucose, 10 mL Bioexpress Cell Growth Media (Cambridge Isotope 
Laboratories, Tewksbury, MA, USA), 10 mL Gibco™ MEM Vitamin Solution (100x), 1 mL 1 M MgSO4, 10 mL 
Trace Metal solution (0.1 g/L ZnSO4, 0.8 g/L MnSO4, 0.5 g/L FeSO4, 0.1 g/L CuSO4, 1 g/L CaCl2) and 50 μg/mL kan-
amycin. Expression was induced 15 min after the media change by IPTG to a final concentration of 0.1 mM, and 
then the culture was incubated at 16 °C, 225 rpm for 20 hours. The cells were harvested by centrifugation at 5,000 g, 
10 min, 4 °C and suspended in 30 mL TES buffer pH 8.0 (3.63 g/L TRIS, 1.86 g/L EDTA, 200 g/L sucrose) together 
with half a tablet Complete Protease Inhibitor (Roche) followed by a centrifugation at 10 min, 4 °C, 6,150 g. The 
supernatant was removed and the cells incubated at room temperature for 10 min before being resuspended in 
25 mL MQ and half a tablet Complete Protease Inhibitor (Roche). The suspension was supplemented with 125 μL 
1 M MgSO4 before the final centrifugation at 13,000 g, 45 minutes. The supernatant was filtered through a 0.22 μm 
Sterile-flip filter unit from Nalgene. Labelled ChBDCHIT1-49 was purified as described above.
Enzymatic Characterization of the Hybrid Proteins. The kinetic parameters of the purified hybrid 
β-lactamases were determined by measuring the rates of nitrocefin (CalBiochem) hydrolysis at different substrate 
concentrations. Initial rates were measured so that less than 10% of substrate was hydrolysed. A protein concen-
tration of 25 ng/mL was used in the presence of 0.1 mg/mL BSA (Fermentas) used as a crowding and stabilizing 
agent. The experiment was performed at 37 °C in PBS (pH 7.5). A spectrophotometer (PowerWave X, TempLab) 
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was used to monitor the formation of the hydrolysis product at 482 nm. Kinetic parameters (kcat, Km and kcat/
Km) were determined for each hybrid protein as described by Matagne and coworkers39. Standard deviations 
were calculated on the basis of the results obtained from 3 technical replicates for each hybrid protein.
NMR Spectroscopy. NMR spectra of 0.2 mM ChBDCHIT1-49 samples in 50 mM Phosphate buffer at pH 5.5 and 
7.0 were recorded at 25 °C on a Bruker Ascend 800 MHz spectrometer Avance III HD equipped with a 5-mm 
Z-gradient CP-TCI (H/C/N) cryogenic probe at the NT-NMR-Center/Norwegian NMR Platform (NNP). NMR 
data were processed using Bruker TopSpin version 3.5. NMR spectral analysis was performed using CARA 
version 1.5.540. A partial backbone assignment was accomplished using HNCA, CBCA(CO)NH, HN(CA)CO, 
HNCO, 15N-HSQC-NOESY and 15N-HSQC spectra.
NMR titration was used to probe the interaction of ChBDCHIT1-49 with its ligands chitotriose (GlcNAc3) 
and chitobiose (GlcNAc2). For GlcNAc3, the titration points were 1.0 mM, 2.4 mM, 4.5 mM, 6.3 mM, 11.6 mM, 
17.1 mM and 25.0 mM. For GlcNAc2, the titration points were 0.5 mM, 1.0 mM, 2.4 mM, 4.5 mM, 8.7 mM, 
12.4 mM, 18.7 mM and 23.9 mM. 1D-proton and 15N-HSQC spectra (at 4096 × 1024 point resolution) were 
recorded for each titration point.
The side-chains of Trp465 and Asn466 were identified based on the partial assignment and their 15N-HSQC 
peaks were used as reporters for the interaction by measuring chemical shift changes in the N and HN atoms of 
the backbone of ChBDCHIT1-49. A compound change in chemical shift, Δδcomp (in ppm) was calculated using the 
following formula: Δδcomp = [(ΔδH)2 + (ΔδN/x)2]1/2. ΔδH is the change in chemical shift of the amide proton 
(ppm), ΔδN is the change in chemical shift of the amide nitrogen (ppm), and x is a constant used to achieve equal 
contributions from changes in N and HN shifts, which was set to 6.541.
Equation (1)42 was used to estimate the dissociation constant (Kd) of the interaction by using Excel to simul-
taneously fit Kd and Qmax (Δδcomp at saturation) for Δδcomp at each ligand concentration, [L] (mM), and the 
protein concentration, [P] (mM), remained constant at 0.2 mM (Fig. S3B).
∆δ =








Alanine Scanning Mutagenesis of the chitin-binding surface of ChBDCHIT1. Residues expected to 
interact with chitin were substituted with alanine. To identify critical amino acids, an excess of purified hybrid 
proteins expressing a mutated ChBDCHIT1-49 domain were mixed with a final chitin magnetic beads concentra-
tion of 2% (v/v; New England BioLabs) and 0.1 mg/mL BSA. A control was conducted with the carrier protein 
BlaP without any inserted ChBDCHIT1. Binding assays were performed at room temperature by orbital mixing of 
the protein-chitin beads suspension during 30 min. Bound proteins were harvested by magnetic attraction and 
washed three times with 500 mM NaCl 20 mM Tris-HCl 1 mM EDTA 0.1% Tween (pH 5.0). Immobilized protein 
levels on chitin beads were determined by incubation of the beads with nitrocefin and monitoring of antibiotic 
hydrolysis over time at 482 nm (RT).
Phylogenetic Analysis. Starting with the sequences of human chitotriosidase (2201442 A), Tachypleus tri-
dentatus (Arthropoda) tachycitin (1DQC_A), and Hevea brasiliensis (Viridiplantae) hevein (AAO63573.1), and 
using an E-value threshold of 1e−5, three separate PHMMER searches were carried out for genome mining on the 
UniProtKB sequence database, through the HHMI Janelia web portal (http://hmmer.janelia.org/; now available 
at http://www.ebi.ac.uk/Tools/hmmer/).
For the HCHT search, only the hit sequences simultaneously featuring a CBM14 domain and a GH18 domain 
were downloaded (both in non-aligned and aligned format). For the two other proteins, all hit sequences were 
downloaded in non-aligned format. A combination of batch identifier mapping through the UniProt web portal 
(http://www.uniprot.org/uploadlists/) and custom Perl scripts (Bio-MUST-Core, D. Baurain, R. R. Léonard, unpub-
lished) was then used to recover the complete taxonomic lineage of each sequence. The three non-aligned sequence 
files were aligned using MAFFT43 and the resulting alignments cleared of partial sequences, defined as lacking more 
than 50% positions of the longest sequence in each alignment (Bio-MUST-Core). Final alignments were then sub-
mitted to phylogenetic inference using either RAxML44 and the PROTGAMMALGF model45, 46 or PhyloBayes47 and 
the CATGTRG model48, 49 to produce the trees. Both models yielded largely unresolved but broadly similar trees.
Based on the downloaded HMMER-aligned HCHT file, two additional alignments corresponding to each one of 
the two domains were generated (Bio-MUST-Core) and used to build two HMM profiles with hmmbuild50. These 
profiles were then pasted on the HHMI Janelia web portal to carry out two separate HMM searches on UniProtKB, 
using an E-value threshold of 1e−5. All hit sequences featuring at least one copy of the corresponding domain 
were downloaded in non-aligned format and further processed as above (MAFFT, Bio-MUST-Core, RAxML/
PhyloBayes) to produce two phylogenetic trees of the CMB14 and GH18 domain families. To locate chitotriosidase, 
tachycitin and hevein sequences in the domains trees, a semi-automated annotation pipeline was developed so as to 
highlight the leaves corresponding to sequences recovered in the three initial PHMMER searches.
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